RxDoctor Payments Data

John Lovett

Wilmington, NCNPI 1114927795

Payments from drug & device makers

$1,826in general payments, 2019–2025

Across 98 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$391
  • Astellas Pharma US Inc$346
  • Dendreon Pharmaceuticals LLC$199
  • Janssen Products, LP$100
  • Pfizer$88
  • AbbVie$81
  • plus $622 from 17 others

What the payments were for

  • Food & beverage$1,64690%
  • Education$18010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson15$391
Astellas Pharma US Inc23$346
Dendreon Pharmaceuticals LLC10$199
Janssen Products, LP1$100
Pfizer7$88
AbbVie(2 entities)5$81
180 Medical, Inc.4$69
Ferring Pharmaceuticals Inc.5$68
Bayer4$65
Endo Pharmaceuticals Inc.4$56
Boston Scientific2$49
Blue Earth Diagnostics2$48
Coloplast3$46
Foundation Medicine, Inc.2$38
Amgen2$37
Smith+Nephew2$30
Laborie Medical Technologies Corp.1$24
Medtronic1$21
AstraZeneca1$20
Avadel Specialty Pharmaceuticals, LLC1$15
Zyla Life Sciences, Inc.1$14
Hollister Incorporated1$13
Myriad Genetic Laboratories, Inc.1$11

Where these figures come from

Is this you, or does something look wrong? →